COMMENT

FDA approves Janus kinase inhibitors Rinvoq and Cibinqo despite safety concerns

Psychedelics: The next trip for CMOs

Over $1bn raised in venture capital funding for gene editing in 2021

COMMENT

Is price control by stealth the future for the United States?

In the absence of state price negotiations, experts continue to explore other ways to introduce price control under federal drug programmes by stealth.

insight

How has AI helped in tackling Covid-19?

Many artificial intelligence tools have been developed in response to the Covid-19 pandemic, but their use has shown mixed results so far

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

FDA approves Janus kinase inhibitors Rinvoq and Cibinqo despite safety concerns

Psychedelics: The next trip for CMOs

Over $1bn raised in venture capital funding for gene editing in 2021

02/14/2022 13:04:03
  • Home | Cutting the carbon footprint of pharma’s supply chain
  • In this issue
  • Contents
  • CSafe Global
  • Mimotopes Company Insight
  • Mimotopes
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • HOF Sonderanlagenbau
  • Comment
  • Is price control by stealth the future for the United States?
  • FDA approves Janus kinase inhibitors Rinvoq and Cibinqo despite safety concerns
  • Psychedelics: the next trip for CMOs
  • Over $1bn raised in venture capital funding for gene editing in 2021
  • Skyepharma
  • In Depth
  • How AI could unlock the medical potential of psychedelics
  • Covid-19 vaccine mixing: could heterologous boosters improve immunity?
  • Uneven supply patterns hinder US rollout of Covid-19 antivirals
  • Cutting the carbon footprint of pharma’s supply chain
  • Molnupiravir supplies dominate in times of Paxlovid scarcity
  • Wek-tec
  • In Data
  • Revealed: pharma leaders in precision, personalised medicine
  • Asia-Pacific is seeing a hiring boom in pharmaceutical cybersecurity roles
  • Venture financing deals in pharma rise in H2 2021
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Controlant Company Insight
  • Controlant
  • Event: Clinical Trial Supply New England 2022
  • Events
  • Next issue